Back to results
US 8,835,650 B1Granted
Substituted imidazolium compounds for treating disease
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to therapeutic compositions comprising substituted imidazoliums having multiple acidic groups. The compounds may be used to treat diseases or conditions such as those associated with bone, cancer, or pain. Compositions, dosage forms, methods of treating diseases or conditions, methods of preparation, and other related embodiments related to the substituted imidazoliums are also described herein.
Claims7
A pharmaceutical dosage form comprising a compound represented by a formula:
- or a salt thereof;
- wherein the compound is at least 1% of the total weight of active agent in the pharmaceutical dosage form;
- wherein each A is independently an acidic functional group wherein the acidic functional group is chosen from the group consisting of CO2H, SO2H, and PO3H2.
A pharmaceutical dosage form comprising:
- (Compound 1), or a salt thereof, in an amount that is at least 1% of the total weight of active agent in the pharmaceutical dosage form.
Dependencies are inferred from the claim text.